HOME >> BIOLOGY >> NEWS
Children's Hospital researcher leads multipronged attack on infant leukemia

While survival rates for childhood leukemia have dramatically improved over the past 30 years, infants with this blood cancer continue to face difficult odds. Infant leukemia resists treatments such as chemotherapy and stem cell transplants that may be effective in older children, and infants are especially vulnerable to treatment side effects.

A new research effort led by a leukemia expert at The Children's Hospital of Philadelphia seeks to harness in-depth understanding of genes and molecular pathways to develop highly specific drugs designed to kill leukemia cells while causing few or no toxic effects on normal cells.

A five-year, $6.25 million Specialized Center of Research (SCOR) grant from the Leukemia & Lymphoma Society brings together a diverse study team of researchers from leading medical centers to develop innovative treatments for infant leukemia. "Our goal is to streamline advances in molecular medicine to find new treatment options," said Carolyn A. Felix, M.D., principal investigator of the SCOR grant. A pediatric oncologist at The Children's Hospital of Philadelphia, Dr. Felix also is a professor of Pediatrics at the University of Pennsylvania School of Medicine.

The society recently announced its grant award in targeted therapies for infant leukemia from its national office in White Plains, N.Y. The SCOR grant draws on research collaborators from a variety of disciplines to discover new approaches to treatment.

In addition to researchers from The Children's Hospital of Philadelphia and the University of Pennsylvania, the grant includes collaborators from the University of New Mexico, Johns Hopkins University, Stanford University and Tulane University.

Especially integral to this effort to advance new treatments from bench to bedside, the investigators also will work closely with the Children's Oncology Group, the cooperative clinical research organization of pediatric cancer centers throughout North
'"/>

Contact: John Ascenzi
Ascenzi@email.chop.edu
267-426-6055
Children's Hospital of Philadelphia
5-Dec-2006


Page: 1 2 3

Related biology news :

1. Doernbecher Childrens Hospital scientist earns coveted Javits award
2. NIH selects Childrens Hospital as Center of Excellence to train future generations of scientists
3. Childrens Hospital Oakland, Calif.s new iron regulation discovery
4. Childrens Hospital Oaklands new maternal diet study
5. Childrens Hospital and Research Center-Oakland presents a new maternal diet study
6. Childrens Hospital Boston presents at the 2006 American Academy of Pediatrics National Conference
7. Genetic research at Childrens Hospital of Pittsburgh reinforces theory of evolution
8. Childrens Hospital Boston presents at the 2006 Pediatric Academic Societies annual meeting
9. UCLA engineering and Mattel Childrens Hospital collaborate to develop childrens heart valve
10. Childrens Hospital Oakland scientist awarded seat on national scientific review board
11. Research center for National Childrens Study to be based in Queens

Post Your Comments:
*Name:
*Comment:
*Email:


(Date:2/21/2020)... ... 21, 2020 , ... Gateway Genomics , a leading developer of direct-to-consumer ... year’s annual Inc. 5000 list of fastest-growing private companies in the United ... be the 17th fastest-growing private company in the state, and #1 in the Health ...
(Date:2/13/2020)... (PRWEB) , ... February 13, 2020 , ... ... announce an exclusive interview with Nobio CEO Yoram Ashery to discuss ... Nobio is a company that combats bacteria to keep people healthy with their ...
(Date:2/7/2020)... , ... February 07, 2020 , ... ... consulting firm for the natural health product, nutraceutical and dietary supplement industries, announces ... been a leader in regulatory expertise and research pertaining to probiotics. We are ...
Breaking Biology News(10 mins):
(Date:1/22/2020)... ... 21, 2020 , ... Microbial Discovery Group LLC (MDG) is ... and Institutional (I&I) Account Manager. Darrell will focus on servicing MDG’s partners with ... 30 years of sales experience working across multiple different market sectors such as; ...
(Date:1/10/2020)... ... January 09, 2020 , ... A new report from ... the vendor qualification process, a critical element of clinical trial set up and ... the vendor qualification process creates delays in initiation in 7% of clinical trials ...
(Date:1/8/2020)... (PRWEB) , ... January 08, 2020 , ... ... metal wire composites that can achieve specific properties for use in harsh environments ... Metal Wire combines up to three metals or alloys to achieve specific ...
(Date:1/7/2020)... ... 07, 2020 , ... Vuja De Sciences (“Vuja De”), a biotechnology startup dedicated ... appointments of Chand Khanna, DVM, PhD, DACVIM (Onc), and Dr. Lee Helman, MD, to ... are delighted to welcome Chand and Lee as new directors. They will be of ...
Breaking Biology Technology:
Cached News: